Editorial: Innovative multidisciplinary insights into the gut-liver axis and cancer.
作者信息
Gundamaraju Rohit, Goh Bey Hing, Singla Rajeev K
机构信息
ER Stress and Mucosal Immunology Lab, School of Health Sciences, University of Tasmania, Launceston, TAS, Australia.
Department of Pharmaceutical Engineering, B V Raju Institute of Technology, Medak, Telangana, India.
出版信息
Front Oncol. 2025 Apr 22;15:1588708. doi: 10.3389/fonc.2025.1588708. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Innovative multidisciplinary insights into the gut-liver axis and cancer.社论：关于肠-肝轴与癌症的创新性多学科见解
Front Oncol. 2025 Apr 22;15:1588708. doi: 10.3389/fonc.2025.1588708. eCollection 2025.
2
Exploring the role of gut microbiota in colorectal liver metastasis through the gut-liver axis.通过肠-肝轴探讨肠道微生物群在结直肠癌肝转移中的作用。
Front Cell Dev Biol. 2025 Mar 13;13:1563184. doi: 10.3389/fcell.2025.1563184. eCollection 2025.
3
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer.肠道微生物群介导的肠-肝轴：理解和治疗肝癌的突破点。
Clin Mol Hepatol. 2025 Apr;31(2):350-381. doi: 10.3350/cmh.2024.0857. Epub 2024 Dec 11.
4
The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.肠-肝轴：宿主微生物群相互作用塑造肝癌发生。
Trends Cancer. 2022 Jul;8(7):583-597. doi: 10.1016/j.trecan.2022.02.009. Epub 2022 Mar 21.
5
The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.免疫细胞在肝脏肿瘤微环境中的作用：肠道微生物群衍生因子的参与
Int Immunol. 2022 Sep 6;34(9):467-474. doi: 10.1093/intimm/dxac020.
6
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond.肠道-肝脏轴在非酒精性脂肪性肝病/非酒精性脂肪性肝炎、肝癌及其他疾病发病机制中的作用的最新研究进展。
Hepatol Commun. 2023 Aug 28;7(9). doi: 10.1097/HC9.0000000000000241. eCollection 2023 Sep 1.
7
Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.肠-肝轴介导的肝癌发生机制：特别关注肠道微生物群的作用。
Cancer Sci. 2021 Nov;112(11):4433-4443. doi: 10.1111/cas.15142. Epub 2021 Sep 27.
8
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification.肝细胞癌免疫治疗中的肠道微生物群：免疫微环境重塑与肠道微生物群修饰
Gut Microbes. 2025 Dec;17(1):2486519. doi: 10.1080/19490976.2025.2486519. Epub 2025 Apr 1.
9
Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy.肠道细菌对2型糖尿病的影响：机制与治疗策略
World J Diabetes. 2025 Jan 15;16(1):100376. doi: 10.4239/wjd.v16.i1.100376.
10
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases.肝病进展中肠-肝轴的分子和细胞介质
Front Med (Lausanne). 2021 Sep 28;8:725390. doi: 10.3389/fmed.2021.725390. eCollection 2021.
本文引用的文献
1
The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.肠-肝轴：宿主微生物群相互作用塑造肝癌发生。
Trends Cancer. 2022 Jul;8(7):583-597. doi: 10.1016/j.trecan.2022.02.009. Epub 2022 Mar 21.
2
Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.肠-肝轴介导的肝癌发生机制：特别关注肠道微生物群的作用。
Cancer Sci. 2021 Nov;112(11):4433-4443. doi: 10.1111/cas.15142. Epub 2021 Sep 27.
3
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.肠-肝轴在免疫重塑中的作用：肝脏疾病的新见解。
Int J Biol Sci. 2020 Jun 23;16(13):2357-2366. doi: 10.7150/ijbs.46405. eCollection 2020.
4
Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship.肠-肝轴在肝脏炎症、纤维化和癌症中的作用：特别关注肠道微生物群的关系
Hepatol Commun. 2019 Mar 1;3(4):456-470. doi: 10.1002/hep4.1331. eCollection 2019 Apr.
5
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.肥胖诱导的肠道微生物代谢物通过衰老分泌组促进肝癌。
Nature. 2013 Jul 4;499(7456):97-101. doi: 10.1038/nature12347. Epub 2013 Jun 26.
6
Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.肠道微生物群和 TLR4 促进肝细胞癌的发生。
Cancer Cell. 2012 Apr 17;21(4):504-16. doi: 10.1016/j.ccr.2012.02.007.
Zotero 插件